Holen Sie sich die Stockscreener-App
57.23
4.57%
2.50
Schlusskurs vom Vortag:
$54.73
Offen:
$55.36
24-Stunden-Volumen:
1.98M
Relative Volume:
0.83
Marktkapitalisierung:
$8.71B
Einnahmen:
$3.46B
Nettoeinkommen (Verlust:
$-9.40M
KGV:
-238.06
EPS:
-0.2404
Netto-Cashflow:
$51.30M
1W Leistung:
+3.72%
1M Leistung:
+33.87%
6M Leistung:
+28.15%
1J Leistung:
+48.92%
1-Tages-Spanne:
$54.27
$57.45
1-Wochen-Bereich:
$52.90
$57.45
52-Wochen-Spanne:
$28.53
$64.54
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
57.23 | 8.71B | 3.46B | -9.40M | 51.30M | -0.2404 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | Eingeleitet | Goldman | Sell |
| 2025-11-20 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-10 | Eingeleitet | UBS | Neutral |
| 2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
| 2024-10-15 | Eingeleitet | Barclays | Overweight |
| 2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-21 | Eingeleitet | UBS | Buy |
| 2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Eingeleitet | Goldman | Sell |
| 2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-24 | Bestätigt | Needham | Strong Buy |
| 2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-05-06 | Bestätigt | Needham | Strong Buy |
| 2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Hochstufung | UBS | Sell → Neutral |
| 2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Bestätigt | BTIG Research | Buy |
| 2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Bruker Corp (BRKR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Fidelity Multi-Strategy Credit Fund's Bruker Corp(BRKRP.PFD) Holding History - GuruFocus
Bruker Gains 50.3% in a Year: What's Driving the Rally? - Yahoo Finance
Bruker-imec Project Advances Semiconductor Metrology Technique | Industry News | Jun 2026 - Photonics Spectra
Bruker Corp (BRKR) Stock Up 4.5% and Still Undervalued -- GF Sco - GuruFocus
Bruker Corp (BRKR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bruker Corp (BRKR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bruker Corp (BRKR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bruker Corp (BRKR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bruker (BRKR) EVP exercises options, sells 2,000 pre-planned shares - Stock Titan
Inszone Insurance Services Acquires Sanford, Bruker & Banks, Inc., Adding Over a Century of Experience to Its Roster - Yahoo Finance
Bruker Corp (BRKR) Stock Up 4.4% and Still Undervalued -- GF Sco - GuruFocus
Broker Technologies (BRKR) files Form 144 to sell 2,000 shares (06/15/2026) - Stock Titan
Bruker Q2 2025 Earnings Preview - MSN
Bruker Corporation (NASDAQ: BRKR) files S-3 shelf for equity, debt and resale offerings - Stock Titan
Bruker Corp (BRKR) Stock Down 4.0% -- Now Undervalued? GF Score: 85/100 - GuruFocus
What Bruker (BRKR)'s Expanded Diagnostics and Energy-Research Tools Portfolio Means For Shareholders - Yahoo Finance
BRKR News | BRUKER CORP (NASDAQ:BRKR) - ChartMill
Bruker advances 4D proteomics, functional proteoform analysis and hybrid metabolomics at ASMS 2026 - Select Science
J.P. Morgan Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $65 - 富途牛牛
Is Bruker Corporation (BRKR) A Good Stock To Buy Now? - Yahoo Finance
Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam - Yahoo Finance
BRKR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Legal & General Group Plc Sells 43,599 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker Corporation (NASDAQ:BRKR) Given Average Rating of "Hold" by Brokerages - MarketBeat
Bruker (BRKR) Up 37.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Bruker (BRKR) Showcases Innovations in Microbiology at ASM Micro - GuruFocus
Bruker (BRKR) Advances Microbial Diagnostics at ASM Microbe 2026 - GuruFocus
Bruker showcases expanded microbiology diagnostics portfolio By Investing.com - Investing.com Canada
Bruker showcases expanded microbiology diagnostics portfolio - Investing.com
Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026 - Caledonian Record
Bruker Corporation $BRKR Shares Bought by BNP Paribas Financial Markets - MarketBeat
Is Bruker Corp (BRKR) Overvalued After 9.4% Rally? GF Value Says - GuruFocus
Bruker shares jump as new ASMS launches spotlight proteomics, energy, and semiconductor demand - Quiver Quantitative
Bruker Corp. Hits New 52-Week High at USD 58.98 - MarketsMojo
Bruker Corp. Hits Day High with 8.27% Surge in Strong Intraday Performance - Markets Mojo
Bruker Corporation Releases timsMRMS Platform for Analysis of Complex Chemical Mixtures - geneonline.com
Bruker launches timsMRMS system for energy research By Investing.com - Investing.com India
Bruker launches timsMRMS system for energy research - Investing.com
Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry - Yahoo Finance
BofA Securities Maintains Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $65 - 富途牛牛
Wolfe Research Initiates Bruker Corp(BRKR.US) With Hold Rating - Moomoo
Bruker (BRKR) Faces Downgrade from Wolfe Research - GuruFocus
Wolfe Research initiates Bruker stock coverage with Peerperform - Investing.com UK
Wolfe Research initiates Bruker stock coverage with Peerperform By Investing.com - Investing.com Nigeria
Bruker (BRKR) Launches Innovative timsMRMS System - GuruFocus
Is It Time To Consider Buying Bruker Corporation (NASDAQ:BRKR)? - Moomoo
Bruker to pay $3.9844 per share to preferred holders Mar. 2 - Stock Titan
Bruker launches air exposomics tools to link pollution and disease - Stock Titan
Bruker unveils MyGenius PRO diagnostics system - MSN
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bruker Corp-Aktie (BRKR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Jun 15 '26 |
Sale |
54.76 |
2,000 |
109,520 |
128,443 |
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):